PBPeter J. Belin

Peter J. Belin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter J. Belin has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Jules Winokur

    Department of Ophthalmology, Northwell Health, Great Neck, NY, USA

    3 shared publications
  • Guneet S. Sodhi

    Vitreo Retinal Surgery, P.L.L.C. (G.S.S., P.J.B.), Minneapolis, Minnesota, USA

    2 shared publications
  • Matthew Gorski

    Department of Ophthalmology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, New York

    2 shared publications
  • Vincent Deramo

    Department of Ophthalmology, Northwell Health, Great Neck, NY, USA

    2 shared publications
  • Aaron Nagiel

    Vision Center - Ophthalmology, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, CA, USA; Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    1 shared publication
  • Aditya Bansal

    From the Department of Ophthalmology and Vision Sciences, University of Toronto (P.L.O., I.M.M., A.P., S.D., W.W.L., P.G.C., H.H., A.B., R.H.M.), Toronto, Ontario, Canada

    1 shared publication

Latest Publications

  • Open Access

    Optical Coherence Tomography Features in Fovea-Off Exudative vs Rhegmatogenous Retinal Detachment

    by Paola L. Oquendo, Guneet S. Sodhi, Sumana C. Naidu, Isabela Martins Melo, Aurora Pecaku, Sueellen Demian, Peter J. Belin, Wei Wei Lee, Panos G. Christakis, Hesham Hamli, et al.


  • Open Access

    Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes

    by Peter J. Belin, Ameay V. Naravane, Siying Lu, Charles Li, Flora Lum, Polly A. Quiram


  • Trends in the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments During the First Year of the COVID-19 Pandemic

    by Rusdeep Mundae, Adrian Velez, Guneet S. Sodhi, Peter J. Belin, James M. Kohler, Edwin H. Ryan, Peter H. Tang


  • COST ANALYSIS OF SCLERAL BUCKLE, PARS PLANA VITRECTOMY, AND PARS PLANA VITRECTOMY WITH SCLERAL BUCKLE FOR RETINAL DETACHMENT REPAIR

    by Peter J. Belin, Nicholas A. Yannuzzi, Sushant Wagley, William E. Smiddy, Edwin H. Ryan

    Purpose: To compare the cost and utility of scleral buckle (SB), pars plana vitrectomy (PPV), and PPV with SB (PPV/SB) for moderately complex rhegmatogenous retinal detachment repair. Methods: Cost-utility analysis using data from the Primary Retinal Detachment Outcomes Study. The model estimated costs, lifetime utility, and lifetime cost per quality-adjusted life year for treatment of moderately complex rhegmatogenous retinal detachment with SB, PPV, or PPV/SB. Data from the Centers for Medicare and Medicaid Services were used to calculate costs in hospital and ambulatory surgery center settings. Results: Total costs (2020 US dollars) for repair of a moderately complex rhegmatogenous retinal detachment in hospital (ambulatory surgery center) settings were $5,975 ($3,774) for the SB group, $8,125 ($5,082) for the PPV group, and $7,551 ($4,713) for the PPV/SB group. The estimated lifetime quality-adjusted life years gained were 5.4, 4.7, and 4.7 in the SB, PPV, and PPV/SB groups, respectively. The cost per quality-adjusted life year for hospital and ambulatory surgery center settings was $1,106 a ($699) for the SB group, $1729 ($1,081) for the PPV group, and $1,607 ($1,003) for the PPV/SB group. Conclusion: Scleral buckle, PPV, and PPV/SB yielded very favorable cost-utility results for the repair of moderately complex rhegmatogenous retinal detachment, with slightly better results for SB, compared with current willingness to pay standards.


  • Traumatic Retinal Detachment in Patients with Self-Injurious Behavior

    by Elizabeth J. Rossin, Irena Tsui, Sui Chien Wong, Kirk K. Hou, Supalert Prakhunhungsit, Michael P. Blair, Michael J. Shapiro, Lisa Leishman, Aaron Nagiel, Jacob A. Lifton, et al.


  • EXTERNAL DRAINAGE OF SUBRETINAL FLUID DURING RHEGMATOGENOUS RETINAL DETACHMENT REPAIR

    by Peter J. Belin, Rusdeep Mundae, Jonathan H. Tzu, Emmanuel Chang, David W. Iii Parke

    Purpose: To describe the safety and efficacy of rhegmatogenous retinal detachment (RRD) repair with external drainage of subretinal fluid using a 28-gauge External Drainage and Depression device (Vortex Surgical, Chesterfield, MO). Methods: Retrospective review of patients who underwent primary rhegmatogenous retinal detachment repair with scleral buckle, pars plana vitrectomy, or scleral buckle/pars plana vitrectomy using the drainage device from August 2018 through March 2020, performed by four surgeons at two vitreoretinal practices. Results: Eighty-three eyes of 83 patients were included. At presentation, 28% had proliferative vitreoretinopathy. Surgery included 65% scleral buckle/pars plana vitrectomy, 33% pars plana vitrectomy, and 2% scleral buckle. There were no cases of retinal incarceration and two subretinal hemorrhages at the drainage site (both < 2 DD), 2 cases of recurrent RD with proliferative vitreoretinopathy (1 had proliferative vitreoretinopathy at presentation), and 6 (10%) new epiretinal membranes (3 were mild). There were no other complications. Mean follow-up was 274 days. Single operation success rate for those with ≥ 6-month follow-up was 97% (57/59). Conclusion: External drainage of subretinal fluid during rhegmatogenous retinal detachment repair demonstrated a favorable safety profile with a high single operation success rate. Further study of the role of external drainage in rhegmatogenous retinal detachment repair is warranted.


  • Incidence and Risk of Scleral-Fixated Akreos (AO60) Lens Opacification: A Case Series

    by Peter J. Belin, Jang H. Kim, Ahmed Sheikh, Jules Winokur, David Rhee, Vincent Deramo

    Postoperative hydrophilic intraocular lens opacification can lead to decreased vision and may require intraocular lens exchange. This study aims to identify the incidence of scleral-fixated Akreos AO60’s (Bausch + Lomb) lens opacification and risk factors for this phenomenon. This is a retrospective case series of all patients who underwent scleral-fixated Akreos AO60 lens at our institution between January 1, 2015 and December 31, 2019. The following data were recorded: age, sex, medical history, indication for Akreos AO60 implantation, laterality, ocular history, previous ocular surgical procedures, subsequent intraocular surgical procedures after the Akreos implantation, lens opacification, visual significance of opacification, and Akreos explantation. Intraoperative and postoperative complications were recorded. Main outcome measures were the overall incidence of Akreos lens opacification as well as the incidence of these eyes undergoing subsequent intraocular surgery. A total of 262 eyes of 257 patients underwent Akreos lens implantation. Overall, 2% (5 of 262) developed lens opacification. Two patients had Descemet stripping automated endothelial keratoplasty (DSAEK) concurrently with Akreos implantation. One patient underwent subsequent Baerveldt glaucoma implantation and DSAEK. The fourth patient had vitrectomy with sulfur hexafluoride gas followed by DSAEK. This represents a 25% (4 of 16) opacification rate among all patients who underwent DSAEK (P ≤ .01, Fisher exact test). One patient developed opacification after undergoing 2 vitrectomies for retinal detachment in the absence of DSAEK. Akreos lens opacification can be visually significant and may occur after a retinal or corneal procedure that involves the use of intraocular gas or air.


  • Innovations in Secondary Intraocular Lens Placement

    by Peter J. Belin, Sherief Raouf, Ronni M. Lieberman

  • Open Access

    Characteristics and Incidence of Inpatient Ophthalmology Consultations to Screen for Papilledema

    by Peter J. Belin, Giovanni H. Greaves, Jules Winokur, Matthew Gorski

    Objective A frequent reason for ophthalmology consultation is to rule out papilledema. The purpose of this study is to evaluate the incidence of consultations to screen for papilledema in an acute inpatient setting and determine the frequency and factors associated with a positive diagnosis of bilateral optic nerve swelling. Methods A retrospective chart review was performed of consecutive adult and pediatric inpatient ophthalmology consultations at a tertiary hospital system to “rule out papilledema” from September through November 2016. All patients had a detailed neuro-ophthalmology examination including a dilated fundus exam. Results A total of 36 consults—13 males and 23 females—with a mean age of 19.8 (range: 3–71) years were called to screen for papilledema. The most common service to request the consult was pediatrics (44%), followed by neurosurgery (42%), medicine (8%), and neurology (6%). The most frequent reason for consultation was headache (61%), followed by visual changes (30.5%) and nausea/vomiting (25%). A positive diagnosis of bilateral optic nerve swelling occurred in 14% (5/36) of consults. Of these five consults, four of them were sent into the hospital by an ophthalmologist who noted the bilateral optic nerve swelling and one was noted by an emergency room pediatrician. Conclusion No new cases of bilateral optic nerve swelling were found in screening consults to “rule out papilledema.” All of the positive diagnoses in our study had been previously identified by another physician and known to the primary team prior to ophthalmology consultation. Screening consultations for optic nerve swelling may not be an effective way to rule out papilledema.


  • Open Access

    Neuroimaging in the Emergency Department for Patients with Symptoms of Vitreoretinal Traction

    by Adnan Malick, Peter J. Belin, Vincent Deramo, Jules Winokur, Matthew Gorski, Dorjan Pantic, Evan R. Schloss, David Fastenberg

    Eye conditions result in 2.4 million emergency department (ED) visits annually. The purpose of this study is to investigate the management of patients with symptoms of vitreoretinal traction. Retrospective observational study was performed in three Northwell Health EDs between January 2014 and January 2017. Patients with monocular flashes, floaters, or changes in visual field for whom ophthalmology were consulted. Ninety-six patients were included (45 female), mean age 58.4 years. Complaints included floaters in 47 (49%), visual field changes in 39 (41%), and flashes in 28 (29%). Eighteen patients (19%) presented with more than one symptom. Of 24 patients with documented eye examinations by emergency physicians, 10 included confrontational visual fields (CVF). Before ophthalmology consultation, tests included blood work in 29 patients (30%), computerized axial tomography (CT) head in 33 (34%), orbit ultrasound in two (2%), magnetic resonance imaging (MRI) head in 1one (1%), and erythrocyte sedimentation rate (ESR)/C-reactive protein (CRP) in one (1%). Diagnoses by ophthalmologists were posterior vitreous detachment in 44 patients (46%), vitreous hemorrhage in 31 (32%), retinal detachment or tears in 12 (13%), central retinal artery occlusion in six (6%), and central or branch retinal vein occlusions in three (3%). Of 12 patients with retinal detachments or tears, 5 (42%) underwent surgery within 1 week. In patients presenting to the ED with symptoms of vitreoretinal traction, over 30% underwent imaging and blood work before ophthalmology consultation. Signs and symptoms of retinal pathology should be recognized promptly. Triaging, focused examination, and a detailed history may lead to fewer imaging studies and more cost savings.